STOCK TITAN

[Form 4] Cel-Sci Corporation Insider Trading Activity

Filing Impact
(Moderate)
Filing Sentiment
(Positive)
Form Type
4
Rhea-AI Filing Summary

Cel-Sci Corp. (CVM) – Form 4 insider transaction

On 07/25/2025, CEO & Director Geert R. Kersten purchased 29,197 shares of common stock directly from the company at $6.85 per share (July 24 closing price), a transaction worth roughly $0.2 million. Following the acquisition, Mr. Kersten’s direct ownership increased to 72,835 shares. No derivative security activity was reported.

The transaction code “P” denotes a purchase, signalling management confidence. No sales, option exercises, or other disposition activity were disclosed.

Cel-Sci Corp. (CVM) – Transazione interna Form 4

Il 25/07/2025, il CEO e Direttore Geert R. Kersten ha acquistato 29.197 azioni ordinarie direttamente dalla società al prezzo di 6,85 $ per azione (prezzo di chiusura del 24 luglio), per un valore complessivo di circa 0,2 milioni di dollari. Dopo l'acquisizione, la proprietà diretta del Sig. Kersten è aumentata a 72.835 azioni. Non sono state riportate attività su titoli derivati.

Il codice della transazione “P” indica un acquisto, segnalando fiducia da parte della direzione. Non sono state comunicate vendite, esercizi di opzioni o altre attività di disposizione.

Cel-Sci Corp. (CVM) – Transacción interna Formulario 4

El 25/07/2025, el CEO y Director Geert R. Kersten compró 29,197 acciones comunes directamente de la empresa a $6.85 por acción (precio de cierre del 24 de julio), una transacción valorada en aproximadamente $0.2 millones. Tras la adquisición, la propiedad directa del Sr. Kersten aumentó a 72,835 acciones. No se reportaron actividades con valores derivados.

El código de transacción “P” indica una compra, lo que señala confianza de la dirección. No se divulgaron ventas, ejercicios de opciones u otras disposiciones.

Cel-Sci Corp. (CVM) – Form 4 내부자 거래

2025년 7월 25일, CEO 겸 이사인 Geert R. Kersten이 회사로부터 직접 29,197주의 보통주를 주당 6.85달러(7월 24일 종가)에 매수했으며, 거래 금액은 약 20만 달러에 달합니다. 이번 인수로 Kersten 씨의 직접 보유 주식은 72,835주로 증가했습니다. 파생 증권 관련 활동은 보고되지 않았습니다.

거래 코드 “P”는 매수를 의미하며, 경영진의 신뢰를 나타냅니다. 매도, 옵션 행사 또는 기타 처분 활동은 공개되지 않았습니다.

Cel-Sci Corp. (CVM) – Transaction d’initié Formulaire 4

Le 25/07/2025, le PDG et directeur Geert R. Kersten a acheté 29 197 actions ordinaires directement auprès de la société au prix de 6,85 $ par action (cours de clôture du 24 juillet), pour une transaction d’environ 0,2 million de dollars. Après cette acquisition, la détention directe de M. Kersten est passée à 72 835 actions. Aucune activité sur titres dérivés n’a été signalée.

Le code de transaction « P » signifie un achat, indiquant la confiance de la direction. Aucune vente, exercice d’options ou autre disposition n’a été divulguée.

Cel-Sci Corp. (CVM) – Form 4 Insider-Transaktion

Am 25.07.2025 kaufte CEO und Direktor Geert R. Kersten 29.197 Stammaktien direkt von der Gesellschaft zum Preis von 6,85 $ pro Aktie (Schlusskurs am 24. Juli), eine Transaktion im Wert von etwa 0,2 Millionen Dollar. Nach dem Erwerb erhöhte sich Herr Kerstens Direktanteil auf 72.835 Aktien. Es wurden keine Aktivitäten mit derivativen Wertpapieren gemeldet.

Der Transaktionscode „P“ steht für Kauf und signalisiert das Vertrauen des Managements. Keine Verkäufe, Optionsausübungen oder sonstige Veräußerungen wurden offengelegt.

Positive
  • CEO insider purchase: 29,197 shares acquired, signalling management confidence.
  • Increased alignment: Direct ownership rises to 72,835 shares, enhancing shareholder alignment.
Negative
  • None.

Insights

TL;DR: CEO adds ~$200k in shares; positive signal but modest size relative to float.

The direct purchase indicates insider confidence after recent share price moves. While $200k is not large for a CEO, the 40% boost in his direct holdings (72,835 vs. prior 43,638) is meaningful. Because no derivatives were involved, the transaction aligns his incentives with common shareholders. However, the single purchase does not necessarily foreshadow operational upside and does little to alter overall ownership structure. Impact: modestly positive sentiment, limited valuation effect.

TL;DR: Clean, straightforward Form 4 with no red flags.

The filing follows Section 16 requirements and shows transparent pricing at the prior day’s close, avoiding preferential terms. Absence of simultaneous sales or derivative grants limits concerns about window-dressing. From a governance lens, the purchase marginally strengthens alignment but does not materially change control dynamics. I view the disclosure as low-risk and mildly supportive of governance quality.

Cel-Sci Corp. (CVM) – Transazione interna Form 4

Il 25/07/2025, il CEO e Direttore Geert R. Kersten ha acquistato 29.197 azioni ordinarie direttamente dalla società al prezzo di 6,85 $ per azione (prezzo di chiusura del 24 luglio), per un valore complessivo di circa 0,2 milioni di dollari. Dopo l'acquisizione, la proprietà diretta del Sig. Kersten è aumentata a 72.835 azioni. Non sono state riportate attività su titoli derivati.

Il codice della transazione “P” indica un acquisto, segnalando fiducia da parte della direzione. Non sono state comunicate vendite, esercizi di opzioni o altre attività di disposizione.

Cel-Sci Corp. (CVM) – Transacción interna Formulario 4

El 25/07/2025, el CEO y Director Geert R. Kersten compró 29,197 acciones comunes directamente de la empresa a $6.85 por acción (precio de cierre del 24 de julio), una transacción valorada en aproximadamente $0.2 millones. Tras la adquisición, la propiedad directa del Sr. Kersten aumentó a 72,835 acciones. No se reportaron actividades con valores derivados.

El código de transacción “P” indica una compra, lo que señala confianza de la dirección. No se divulgaron ventas, ejercicios de opciones u otras disposiciones.

Cel-Sci Corp. (CVM) – Form 4 내부자 거래

2025년 7월 25일, CEO 겸 이사인 Geert R. Kersten이 회사로부터 직접 29,197주의 보통주를 주당 6.85달러(7월 24일 종가)에 매수했으며, 거래 금액은 약 20만 달러에 달합니다. 이번 인수로 Kersten 씨의 직접 보유 주식은 72,835주로 증가했습니다. 파생 증권 관련 활동은 보고되지 않았습니다.

거래 코드 “P”는 매수를 의미하며, 경영진의 신뢰를 나타냅니다. 매도, 옵션 행사 또는 기타 처분 활동은 공개되지 않았습니다.

Cel-Sci Corp. (CVM) – Transaction d’initié Formulaire 4

Le 25/07/2025, le PDG et directeur Geert R. Kersten a acheté 29 197 actions ordinaires directement auprès de la société au prix de 6,85 $ par action (cours de clôture du 24 juillet), pour une transaction d’environ 0,2 million de dollars. Après cette acquisition, la détention directe de M. Kersten est passée à 72 835 actions. Aucune activité sur titres dérivés n’a été signalée.

Le code de transaction « P » signifie un achat, indiquant la confiance de la direction. Aucune vente, exercice d’options ou autre disposition n’a été divulguée.

Cel-Sci Corp. (CVM) – Form 4 Insider-Transaktion

Am 25.07.2025 kaufte CEO und Direktor Geert R. Kersten 29.197 Stammaktien direkt von der Gesellschaft zum Preis von 6,85 $ pro Aktie (Schlusskurs am 24. Juli), eine Transaktion im Wert von etwa 0,2 Millionen Dollar. Nach dem Erwerb erhöhte sich Herr Kerstens Direktanteil auf 72.835 Aktien. Es wurden keine Aktivitäten mit derivativen Wertpapieren gemeldet.

Der Transaktionscode „P“ steht für Kauf und signalisiert das Vertrauen des Managements. Keine Verkäufe, Optionsausübungen oder sonstige Veräußerungen wurden offengelegt.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
KERSTEN GEERT R

(Last) (First) (Middle)
8229 BOONE BLVD
STE 802

(Street)
VIENNA VA 22182

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
CEL SCI CORP [ CVM ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Executive Officer
3. Date of Earliest Transaction (Month/Day/Year)
07/25/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 07/25/2025 P 29,197(1) A $6.85 72,835 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. On July 25, 2025, Mr. Kersten purchased 29,197 shares of restricted stock directly from the Company at the closing price on July 24, 2025, the most recent closing price available.
Geert Kersten 07/28/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Cel-Sci (CVM) shares did CEO Geert Kersten buy?

He purchased 29,197 common shares on 07/25/2025.

What was the purchase price in the July 2025 Form 4 filing?

The shares were bought at $6.85 per share, the prior day’s closing price.

How many CVM shares does the CEO now own directly?

After the transaction, Mr. Kersten holds 72,835 direct shares.

Were any options or warrants involved in this Form 4?

No. No derivative securities were reported as acquired or disposed.

Is the insider transaction considered positive for investors?

Insider purchases typically signal confidence; this filing is viewed as a modestly positive sentiment indicator.
CEL-SCI Corp

NYSE:CVM

CVM Rankings

CVM Latest News

CVM Latest SEC Filings

CVM Stock Data

44.06M
6.73M
2.26%
8.78%
6.87%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
VIENNA